Loading...
Please wait, while we are loading the content...
Similar Documents
Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study
| Content Provider | Scilit |
|---|---|
| Author | Thomas, Anish Vilimas, Rasa Trindade, Christopher Erwin-Cohen, Rebecca Roper, Nitin Xi, Liqiang Krishnasamy, Venkatesh Levy, Elliot Mammen, Andy Nichols, Samantha Chen, Yuanbin Velcheti, Vamsidhar Yin, Faye Szabo, Eva Pommier, Yves Steinberg, Seth M. Trepel, Jane B. Raffeld, Mark Young, Howard A. Khan, Javed Hewitt, Stephen Lee, Jung-Min |
| Copyright Year | 2019 |
| Description | Journal: Journal of Thoracic Oncology |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660419/pdf http://www.jto.org/article/S1556086419303612/pdf |
| Ending Page | 1457 |
| Page Count | 11 |
| Starting Page | 1447 |
| e-ISSN | 15561380 |
| DOI | 10.1016/j.jtho.2019.04.026 |
| Journal | Journal of Thoracic Oncology |
| Issue Number | 8 |
| Volume Number | 14 |
| Language | English |
| Publisher | Elsevier BV |
| Publisher Date | 2019-08-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: Journal of Thoracic Oncology Small Cell Lung Cancer; Parp Inhibitors; Immune Checkpoint Blockade; Tumor Immune Phenotype; Dna Repair |
| Content Type | Text |
| Resource Type | Article |